... clinical data presentations at the San Antonio Breast Cancer Symposium, ... Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company ...
News
- Calithera Biosciences to Host Conference Call and Webcast to Review Data Presented at the San ...
- KU professor's research proves some science textbooks wrong
Haufler's research is reported in the November issue of the journal Bioscience, in an article he co-authored with a group he said one reviewer ...
- Study: IBM Watson agrees with cancer docs on treatment options 90% of the time
At the San Antonio Breast Cancer Symposium, Dr. S. P. Somashekhar, chairman of the Manipal Comprehensive Cancer Center in Bengaluru, India, ...
- Puma Biotechnology, Inc. (NYSE:PBYI) announced interim results from a Phase II clinical trial
Puma Biotechnology, Inc. (NYSE:PBYI) traded 1.42 Million shares and was closed at $36.45 per share. The current share price indicates that stock is ...
- Puma Biotechnology Inc.: Puma Biotechnology Presents Interim Results of Phase II CONTROL ...
... (neratinib) were presented at the 2016 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) that is currently taking place in San Antonio, ...